T2 Biosystems director resigns
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Joshua Bilenker resigned as a class II director of T2 Biosystems Inc., effective Jan. 17.
Bilenker resigned due to other personal commitments and not as a result of any dispute or disagreement with the company or any member of its management.
